This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57462802
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel scientific article published on 01 September 2018 im Oktober 2018 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en setiembre de 2018 наукова стаття, опублікована в жовтні 2018
p:P577
wds:Q57462802-80C830D7-54F1-4FDA-929B-CD955D5A0047
wdt:P577
2018-09-01T00:00:00Z
p:P407
wds:Q57462802-043C7290-0944-4B12-AC59-89E850E7E007
wdt:P407
wd:Q1860
p:P2093
wds:Q57462802-B7E48068-EE89-491B-9AE4-E091E3EE1DB8 wds:Q57462802-4BCB4292-2C38-4893-BA3F-576FE5BF3ABD wds:Q57462802-16BC5302-1111-47C8-B05A-1C3DB24DA244 wds:Q57462802-9F684D64-24E7-4A9F-8F0D-810778AAFC43 wds:Q57462802-7DA4D5BC-607B-4250-8C77-927DA29A90ED
wdt:P2093
Pēteris Alberts Katrīna Bandere Andra Tilgase Dite Venskus Agnija Rasa
rdfs:label
The advent of oncolytic virotherapy in oncology: The Rigvir® story The advent of oncolytic virotherapy in oncology: The Rigvir® story
skos:prefLabel
The advent of oncolytic virotherapy in oncology: The Rigvir® story The advent of oncolytic virotherapy in oncology: The Rigvir® story
schema:name
The advent of oncolytic virotherapy in oncology: The Rigvir® story The advent of oncolytic virotherapy in oncology: The Rigvir® story
p:P1476
wds:Q57462802-BA660AC1-F8C2-48A9-95F8-CB961C58F04D
wdt:P1476
The advent of oncolytic virotherapy in oncology: The Rigvir® story
p:P304
wds:Q57462802-03BE5DE1-6399-4D07-A2BD-6D44B082DB2D
wdt:P304
117-126
p:P31
wds:Q57462802-F0E35ABA-FC15-4EC0-B1F9-104C5E42897E
wdt:P31
wd:Q13442814
p:P921
wds:Q57462802-0AF4C87C-3164-41E7-A589-92AF5C195E71
wdt:P921
wd:Q1560099
p:P698
wds:Q57462802-EFC3D205-40CD-414D-8F0B-7E1CDD436B7A
wdtn:P698
n10:30179611
wdt:P698
30179611
p:P1433
wds:Q57462802-D34A189C-DB65-41F1-A4CD-A3F5A0568FFD
wdt:P1433
wd:Q1376712
p:P478
wds:Q57462802-61DD68A7-F9AF-4629-B26D-BDF4FFF6BAF0
wdt:P478
837
p:P356
wds:Q57462802-ABC36174-17D8-47C4-BD01-24DFFDE057AB
wdtn:P356
n12:J.EJPHAR.2018.08.042
wdt:P356
10.1016/J.EJPHAR.2018.08.042